tiprankstipranks
Trending News
More News >
LifeMD (LFMD)
NASDAQ:LFMD
US Market
Advertisement

LifeMD (LFMD) Earnings Dates, Call Summary & Reports

Compare
660 Followers

Earnings Data

Report Date
Nov 05, 2025
Before Open (Confirmed)
Period Ending
2025 (Q3)
Consensus EPS Forecast
-0.04
Last Year’s EPS
-0.14
Same Quarter Last Year
Based on 4 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Aug 05, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
While LifeMD showcased strong growth in telehealth revenue and a strategic expansion into new healthcare segments, challenges in the weight management segment and RexMD's elevated customer acquisition costs led to a downward revision of financial guidance. The integration of AI and debt-free status are positive indicators, but the challenges faced balance out the highlights.
Company Guidance
During the LifeMD second-quarter earnings call for fiscal year 2025, the company highlighted several key financial metrics and strategic priorities. The telehealth business reported a 30% year-over-year increase in revenue, with adjusted EBITDA growing by 560%. In contrast, challenges in the RexMD business led to temporary elevated customer acquisition costs, impacting overall performance. Weight management remained robust, attracting over 400 new patient sign-ups per day despite a higher-than-expected refund rate due to insurance coverage issues. WorkSimpli generated nearly $3.7 million in adjusted EBITDA on a stand-alone basis. LifeMD revised its 2025 revenue guidance to $250-$255 million, down from $268-$275 million previously, reflecting these temporary challenges. The company emphasized the strategic integration of AI and expansion into high-value clinical areas such as behavioral and women's health, alongside the continued growth of its LifeMD+ membership program. Despite short-term setbacks, LifeMD remains confident in its long-term growth trajectory and strategic initiatives.
Strong Telehealth Revenue Growth
Telehealth revenue increased by 30% year-over-year, with adjusted EBITDA growth of 560%.
WorkSimpli Performance
WorkSimpli generated nearly $3.7 million in adjusted EBITDA on a stand-alone basis, indicating strong performance.
Expansion into Behavioral and Women's Health
LifeMD launched a nationwide behavioral health offering and upcoming women's health program, addressing large underserved markets.
Patient Satisfaction
Patient satisfaction scores averaged 4.91 out of 5, demonstrating the quality and effectiveness of LifeMD's care model.
AI Integration
LifeMD is integrating AI into operations to streamline administrative tasks, improving patient outcomes and provider productivity.
LifeMD+ Membership Traction
The LifeMD+ membership program shows promise with nearly 50 new patient sign-ups per day.
Debt-Free Status
LifeMD fully repaid its senior venture debt, making the business debt-free and saving approximately $1.1 million in future interest payments.

LifeMD (LFMD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

LFMD Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Nov 05, 2025
2025 (Q3)
-0.04 / -
-0.14
Aug 05, 2025
2025 (Q2)
>-0.01 / -0.06
-0.1968.42% (+0.13)
May 06, 2025
2025 (Q1)
-0.05 / 0.01
-0.19105.26% (+0.20)
Mar 10, 2025
2024 (Q4)
-0.05 / -0.02
-0.1283.33% (+0.10)
Nov 07, 2024
2024 (Q3)
-0.12 / -0.14
-0.230.00% (+0.06)
Aug 07, 2024
2024 (Q2)
-0.14 / -0.19
0.05-480.00% (-0.24)
May 08, 2024
2024 (Q1)
-0.15 / -0.19
0.06-416.67% (-0.25)
Mar 11, 2024
2023 (Q4)
-0.14 / -0.12
-0.470.00% (+0.28)
Nov 08, 2023
2023 (Q3)
-0.09 / -0.20
-0.03-566.67% (-0.17)
Aug 09, 2023
2023 (Q2)
-0.10 / 0.05
-0.22122.73% (+0.27)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

LFMD Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 05, 2025
$11.84$6.53-44.85%
May 06, 2025
$7.76$8.01+3.22%
Mar 10, 2025
$4.27$5.58+30.68%
Nov 07, 2024
$5.13$5.85+14.04%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does LifeMD (LFMD) report earnings?
LifeMD (LFMD) is schdueled to report earning on Nov 05, 2025, Before Open (Confirmed).
    What is LifeMD (LFMD) earnings time?
    LifeMD (LFMD) earnings time is at Nov 05, 2025, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is LFMD EPS forecast?
          LFMD EPS forecast for the fiscal quarter 2025 (Q3) is -0.04.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis